Fehrman-Ekholm I - Search Results

1

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.

Suliman ME, Heimbürger O, Bárány P, Anderstam B, Pecoits-Filho R, Rodríguez Ayala E, Qureshi AR, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. Suliman ME, et al. J Am Soc Nephrol. 2003 Jun;14(6):1614-22. doi: 10.1097/01.asn.0000067413.32377.cf. J Am Soc Nephrol. 2003. PMID: 12761263

2

Associations between circulating inflammatory markers and residual renal function in CRF patients.

Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. Pecoits-Filho R, et al. Am J Kidney Dis. 2003 Jun;41(6):1212-8. doi: 10.1016/s0272-6386(03)00353-6. Am J Kidney Dis. 2003. PMID: 12776273

3

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P. Snaedal S, et al. Am J Kidney Dis. 2009 Jun;53(6):1024-33. doi: 10.1053/j.ajkd.2009.02.008. Epub 2009 Apr 25. Am J Kidney Dis. 2009. PMID: 19394732

4

Recovery of renal function after one-year of dialysis treatment: case report and registry data.

Fehrman-Ekholm I, Bergenhag AC, Heimburger O, Schön S. Fehrman-Ekholm I, et al. Int J Nephrol. 2010 Jun 17;2010:817836. doi: 10.4061/2010/817836. Int J Nephrol. 2010. PMID: 21188240 Free PMC article.

5

Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking.

Elinder CG, Ekberg H, Bárány P, Fehrman-Ekholm I, Jensen G, Nordén G, Schön S, Wennberg L, Qureshi AR. Elinder CG, et al. Transpl Int. 2009 Nov;22(11):1051-7. doi: 10.1111/j.1432-2277.2009.00894.x. Epub 2009 May 27. Transpl Int. 2009. PMID: 19497064 Free article.

6

Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance.

Fehrman-Ekholm I, Skeppholm L. Fehrman-Ekholm I, et al. Scand J Urol Nephrol. 2004;38(1):73-7. doi: 10.1080/00365590310015750. Scand J Urol Nephrol. 2004. PMID: 15204431

7

The effects of hemodialysis treatment on the level of DNA strand breaks and oxidative DNA lesions measured by the comet assay.

Ersson C, Odar-Cederlöf I, Fehrman-Ekholm I, Möller L. Ersson C, et al. Among authors: fehrman ekholm i. Hemodial Int. 2013 Jul;17(3):366-73. doi: 10.1111/hdi.12008. Epub 2012 Dec 20. Hemodial Int. 2013. PMID: 23279066

8

Antibodies in alloimmunized uraemic patients treated with recombinant erythropoietin.

Fehrman-Ekholm I, Sumitran-Karuppan S. Fehrman-Ekholm I, et al. Transpl Int. 1994;7 Suppl 1:S290-3. doi: 10.1111/j.1432-2277.1994.tb01370.x. Transpl Int. 1994. PMID: 11271228

9

Incidence of end-stage renal disease among live kidney donors.

Fehrman-Ekholm I, Nordén G, Lennerling A, Rizell M, Mjörnstedt L, Wramner L, Olausson M. Fehrman-Ekholm I, et al. Transplantation. 2006 Dec 27;82(12):1646-8. doi: 10.1097/01.tp.0000250728.73268.e3. Transplantation. 2006. PMID: 17198252

10

No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up.

Fehrman-Ekholm I, Dunér F, Brink B, Tydén G, Elinder CG. Fehrman-Ekholm I, et al. Transplantation. 2001 Aug 15;72(3):444-9. doi: 10.1097/00007890-200108150-00015. Transplantation. 2001. PMID: 11502974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters